We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

New Hands-Free Rapid Test Detects Bacteria in Fluids

By LabMedica International staff writers
Posted on 03 Dec 2024

Bacteriophages, the most abundant form of life on Earth, are specialized to target and destroy specific types of bacteria. More...

Their natural ability to fight bacteria has long been harnessed to treat infections. Now, researchers have developed a novel test that uses harmless bacteriophages to detect disease-causing bacteria in fluids. This test enables even untrained users to identify bacterial contamination in liquids using a biogel that changes color when exposed to bacteria like E. coli, listeria, and other common pathogens.

The test, developed by a team of engineers and biochemists at McMaster University (Hamilton, ON, Canada) utilizes bacteriophages embedded in a gel to detect bacteria in fluid samples, including urine, even at low concentrations. In the test, the bacteriophages target and attack specific bacteria in the sample. As the bacteria are destroyed, they release small amounts of intracellular material that the test can detect, causing the gel to change color. If no bacteria are present, the color remains unchanged. This process takes just hours to provide results, significantly faster than traditional lab cultures, which can take up to two days. The test, detailed in a paper published in Advanced Materials, is part of a broader effort by researchers to develop simple technologies accessible to consumers, medical professionals, and industries.

The team had previously worked on creating a portable library of tests using phages to combat antibiotic-resistant infections. To validate the new test, the researchers used urine samples from patients at Hamilton Health Sciences, and the results were consistent with those of traditional lab methods. This new test can be customized for any bacteria by utilizing specific bacteriophages and DNA probes targeting microbes like listeria and salmonella. The ability to test complex fluids, such as blood and urine, for contamination is particularly challenging, and the simplicity and reliability of this new test make it a valuable tool. The researchers hope to collaborate with commercial partners to bring this innovation to the market.

“Today, people who suspect they may have a urinary-tract infection must visit a doctor and sometimes wait days for a result. This technology would make it very easy for people to tests themselves at home and get a result in a matter of hours,” said corresponding author Tohid Didar, an associate professor of mechanical and biomedical engineering who holds the Canada Research Chair in Nano-Biomaterials.


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.